Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

STRYKER CORPORATION

(SYK)
  Report
Delayed Quote. Delayed Nyse - 10/22 04:10:00 pm
275.73 USD   -0.26%
10/11STRYKER : to host analyst meeting
AQ
09/29STRYKER CORPORATION : Ex-dividend day for
FA
09/23STRYKER : to host conference call on October 28, 2021
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Stryker : Buys Gauss Surgical for Undisclosed Sum

09/08/2021 | 04:18am EDT


© MT Newswires 2021
All news about STRYKER CORPORATION
10/11STRYKER : to host analyst meeting
AQ
09/29STRYKER CORPORATION : Ex-dividend day for
FA
09/23STRYKER : to host conference call on October 28, 2021
AQ
09/15Stryker Launches New Tendon Fixation Device System
CI
09/09VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming
DJ
09/08STRYKER : Buys Gauss Surgical for Undisclosed Sum
MT
09/07Stryker Corporation acquired Gauss Surgical, Inc.
CI
09/01STRYKER : Stuart F. Simpson is THINK Surgical's New President and Chief Executive Officer
PR
08/30Stryker to participate in Morgan Stanley's 19th Annual Global Healthcare Conference
GL
08/24Stryker Launches T2 Alpha Femur Retrograde Nailing System
CI
More news
Analyst Recommendations on STRYKER CORPORATION
More recommendations
Financials (USD)
Sales 2021 17 277 M - -
Net income 2021 2 521 M - -
Net Debt 2021 9 458 M - -
P/E ratio 2021 40,9x
Yield 2021 0,92%
Capitalization 104 B 104 B -
EV / Sales 2021 6,57x
EV / Sales 2022 5,99x
Nbr of Employees 43 000
Free-Float 92,7%
Chart STRYKER CORPORATION
Duration : Period :
Stryker Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRYKER CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 31
Last Close Price 275,73 $
Average target price 283,84 $
Spread / Average Target 2,94%
EPS Revisions
Managers and Directors
Kevin A. Lobo Chairman, President & Chief Executive Officer
Glenn S. Boehnlein Chief Financial Officer & Vice President
Alan Douville Chief Information Officer & Vice President
Dana S. McMahon Chief Compliance Officer & Vice President
Howard E. Cox Director-Emeritus
Sector and Competitors